ACP
Audalia Resources Limited
🇦🇺 ASX
⛏️ MINING
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 46.67%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Audalia Resources Ltd. engages in the exploration of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-07-06. The firm's Medcalf Project is a vanadium-titanium-iron project located approximately 470 kilometers (kms) southeast of Perth near Lake Johnston, Western Australia. The Medcalf Project lies in the southern end of the Archaean Lake Johnston greenstone belt. The greenstone belt is a narrow, north-northwest trending belt approximately 110 kms in length. The Medcalf Project comprises of one granted exploration license E63/1855, two miscellaneous licenses L63/75 and L63/94, and two General Purpose licenses G63/10 and G63/12 as well as mining lease M63/656. Together these licenses cover a total area of 38 square kilometers. The firm has developed two products in the market from the Medcalf Project. The products include high titanium lump ore and concentrate fine ore. The firm also applied for three exploration licenses within a 30km radius of the Medcalf Project.
📈 Performance
Price History
-87.10%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ACP
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ACP
N/A
ACP investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in ACP also invest in...
Want more shares? Try these...
Acorn Capital Investment Fund Ltd is a AU-based company operating in industry. The company is headquartered in Melbourne, Victoria and currently employs 0 full-time employees. The company went IPO on 2014-05-01. Acorn Capital Investment Fund Limited is an Australia-based investment company. The principal activity of the Company is to invest in a portfolio of listed and unlisted microcap companies. The objective of the Company is to create a diversified portfolio of listed microcap companies and then to invest opportunistically in unlisted entities that offer better relative value. The firm invests in various sectors, including consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials, communication services, utilities, financials and cash. The Company’s investment manager is Acorn Capital Limited.
🙌 Performance (5Yr p.a)
-5.69%
📊 Share price
$0.83 AUD
💰 HIGH DIVIDEND
Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-29. The firm is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
🙌 Performance (5Yr p.a)
-16.53%
📊 Share price
$0.03 AUD
📦 LOGISTICS
Australian Critical Minerals Ltd. engages in exploration of lithium and rare earth metals. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2023-07-03. The key projects are the Cooletha (Pilbara) Lithium Project and the Rankin Dome (Southern Cross) Rare Earth Project. The Cooletha (Pilbara) Lithium Project is the Company’s flagship lithium project, with over 100 square kilometers of prospective ground in the Pilbara. The Rankin Dome (Southern Cross) Rare Earth Project consists of three exploration licenses in the Youanmi Terrane near Southern Cross. Its Pilbara portfolio covers over 494 square kilometers, including the Shaw and Cooletha Iron Ore Projects. The Cooletha Project, covering over 400 square kilometers of ground in the Pilbara, is highly prospective for iron ore. The Shaw Project of almost 100 square kilometers of ground is prospective for iron ore in banded iron formation. Its other projects include Beverley, Kondinin and Kojonup Kaolin.
📊 Share price
$0.09 AUD
⛏️ MINING
